Entact Bio

About:

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Website: https://entactbio.com

Twitter/X: entactbio

Top Investors: Walter and Eliza Hall Institute of Medical Research, venBio Partners, 4BIO Capital, Surveyor Capital, Abingworth

Description:

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed to create enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.